Developer docs
API playgroundTry for free, no card

Search company profiles

MTL Cannabis

Full company profile

uuid00yokfx

Namestring
MTL Cannabis
Legal namestring
MTL Cannabis Corp.
Websiteurl
mtlcannabis.ca
Company typeenum
Private
Founded yearint
2020
Descriptiontext

MTL Cannabis is a Canadian licensed cultivator and processor of premium indoor-grown cannabis, founded in 2020 by Montreal brothers Rich and Mitch Perron. The company operates a flower-first portfolio spanning dried flower strains (Sage n' Sour, Cookies n' Cream, Strawberry n' Mintz, Jungl' Cake, Wes' Coast Kush, East Coast Dank'z, Dante'z Inferno, Gas n' Up, 91 OX), hash products (Sage n' Sour Hash, Wes' Coast Kush Hash), and prerolls (Lemon' Ball'r, Apple Sau'z, Dank Sti'x). Core technology centers on an indoor hydroponic cultivation system with a defined 5-step artisan process — indoor cultivation, hang-drying, cold curing, hand thumb trimming, and hand packing — producing flower with THC content ranging from 18-36% depending on strain. Sub-brands LowKey (award-winning dessert strains), R'Belle (Quebec-exclusive sold through SQDC), and MTL Craft (micro-cultivation aggregator) segment the market by price point, geography, and production scale.

MTL Cannabis generates revenue through two primary streams: recreational cannabis sold through provincial distributors and licensed retailers across all Canadian provinces, and medical cannabis distributed through its subsidiaries ABBA Medix Corp. (an online medical marketplace sourcing 450+ SKUs from 60+ brands) and Canada House Clinics Inc. (medical document issuance and patient education). The company sells directly to budtenders and retailers through a dedicated sales channel ([email protected]) and operates the 5 à Sesh product knowledge training program for retail staff. Additional subsidiaries include Montréal Cannabis Médical Inc. (licensed cultivator/processor) and IsoCanMed Inc. (medical cannabis cultivation).

Following the August 2023 listing on the CSE under symbol MTLC and achieving $83.1M in FY2024 revenue, MTL Cannabis was acquired by Canopy Growth Corporation in March 2026 for approximately CA$125 million. The acquisition integrated MTL's patient network, clinics, online medical channel, and premium flower supply into Canopy's operations, positioning the combined entity as Canada's leading medical cannabis business by revenue. The deal targets approximately $10M in run-rate cost synergies within 18 months and supports Canopy Growth's fiscal 2027 positive adjusted EBITDA target. MTL Cannabis now operates as a wholly-owned subsidiary of Canopy Growth (NASDAQ: CGC).

Short descriptiontext

MTL Cannabis is a Canadian licensed cultivator and processor of premium indoor-grown recreational and medical cannabis, serving provincial retailers, medical patients, and veterans. Acquired by Canopy Growth in March 2026 for CA$125 million, it now operates as a wholly-owned subsidiary.

Operating statusenum
Acquired
Ownership categoryenum
akta.pro rankint
HeadquartersMontreal, Canada
HQ citystring
Montreal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
indoor cannabis cultivation, medical cannabis marketplace, cannabis flower products, cannabis prerolls and hash, licensed cannabis producer
Industry3 codes
1Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
CodeCRANAFAIPrimaryYes
2Medical Cannabis Dispensaries
CodeCRANAFABPrimaryNo
3Adult-Use (Recreational) Cannabis Dispensaries
CodeCRANAFAAPrimaryNo
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing32541
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Cannabis Cultivation and Distribution
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Recreational Cannabis Sales
TypeOne Time License
Description

MTL Cannabis sells recreational cannabis products (dried flower, prerolls, hash) through provincial board distributors across Canada. Revenue is generated through product sales at retail. The company claims Canada's leading medical cannabis business by revenue following its Canopy Growth acquisition.

theglobeandmail.com
2Medical Cannabis Sales
TypeTransaction Fee
Description

Through subsidiaries Abba Medix Corp. (a medical marketplace sourcing 450+ SKUs from 60+ brands and licensed producers) and Canada House Clinics Inc. (providing medical documents and education services), MTL serves medical cannabis patients including veterans. Revenue is generated through medical cannabis sales to patients.

mtlcannabis.ca
3Wholesale / B2B Flower Supply
TypeOne Time License
Description

MTL Cannabis supplies its premium flower products to retailers and budtenders across Canada, including through its own brand portfolio and sub-brands (LowKey, R'Belle for Quebec, MTL Craft for micro-cultivator showcase).

mtlcannabis.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1LowKey
Description

Premium cannabis brand featuring strains like Haze, Sativa, and Dessert varieties. LowKey won the 2023 Karma Cup award for Best Hybrid with Apple Fritter.

mtlcannabis.ca
+2 more records
Core offering1 text field

MTL Cannabis is a flower-first Canadian licensed cultivator and processor that produces and distributes premium indoor-grown cannabis dried flower, prerolls, and hash products. The company operates a five-step artisan production process (indoor cultivation, hang-drying, cold curing, hand trimming, hand packing) across three growing facilities in Canada. Through subsidiaries Abba Medix and Canada House Clinics, it also operates a medical cannabis marketplace and clinic services for veterans and other medical patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • MTL Cannabis was positioned as Canada's leading medical cannabis business by revenue following its acquisition by Canopy Growth in March 2026.
+3 more records
Product overview1 text field

MTL Cannabis is a flower-first Canadian cannabis company offering premium indoor-grown, hang-dried, cold-cured, and hand-trimmed cannabis products. The portfolio spans core dried flower strains (Sage n' Sour, Cookies n' Cream, Strawberry n' Mintz, Jungl' Cake, Wes' Coast Kush, East Coast Dank'z, Dante'z Inferno, Gas n' Up, 91 OX), hash products (Sage n' Sour Hash, Wes' Coast Kush Hash), and prerolls (Lemon' Ball'r, Apple Sau'z, Dank Sti'x). The company operates three sub-brands: MTL Craft (small-batch artisan micro-cultivation via Abba Medix), LowKey (award-winning strains including Karma Cup Best Hybrid winner Apple Fritter), and R'Belle (Quebec-exclusive). The 5 à Sesh program provides budtender education on the hydroponic system and 5-step artisan production process.

Product and service14 records
1Sage n' Sour
CategoryDried Cannabis Flower
Description

Signature hybrid strain (Sour Diesel x S.A.G.E.) with diesel, peppery, lemon, and cedar notes. THC content 24-30%. Available in 1 oz format for adult-use recreational consumers across Canadian provinces.

2Cookies n' Cream
CategoryDried Cannabis Flower
Description

Hybrid strain (Starfighter x Girl Scout Cookies phenotype) with sweet pastry, hazelnut, tart, and floral flavors. THC 18-25%, CBG 1-2%. Balanced 50% Sativa / 50% Indica.

3Strawberry n' Mintz
CategoryDried Cannabis Flower
Description

Sativa-dominant hybrid (Strawberry Guava x Kush Mints) featuring fresh berry, minty, and earthy flavors. THC 30-36%. Available in 15g and prerolls.

4Jungl' Cake
CategoryDried Cannabis Flower
Description

Indica-dominant hybrid (White Fire x Wedding Cake) with sweet pastry, marshmallow, and nutty notes. THC 28-34%. Available in 1/2 oz format.

5Wes' Coast Kush
CategoryDried Cannabis Flower
Description

Indica-dominant hybrid (OG Kush x hybrid blend) with sweet, earthy, spicy, and diesel flavors. THC 28-36%. Available in 1/2 oz and prerolls.

6East Coast Dank'z
CategoryDried Cannabis Flower
Description

Indica (Grape Gas x Gelato) with diesel, sweet, peppery, and spicy notes. THC 26-31%, CBD under 1%. Available in 7g and prerolls (3x0.5g).

7Dante'z Inferno
CategoryDried Cannabis Flower
Description

Hybrid (Oreoz x Devil Driver) with cookie dough, campfire smores, earthy, spicy, and citrus notes. THC 28-33%. Available in 14g format.

8Gas n' Up
CategoryDried Cannabis Flower
Description

Indica (Venom OG x Humboldt OG) with spicy diesel, black pepper, and earthy wood flavors. THC 27-33%. Available in prerolls.

991 OX
CategoryDried Cannabis Flower
Description

Indica-dominant (Biscotti x Scotty2Hotty) with diesel, spicy biscuit, and floral notes. THC 27-33%. Available in 3.5g and prerolls.

10Lemon' Ball'r
CategoryCannabis Prerolls
Description

Preroll combining Sage n' Sour hash with Sage n' Sour flower, featuring lemon, diesel, and citrus flavors. Dominant terpene: Terpinolene. THC 21-27% in Quebec.

11Apple Sau'z
CategoryCannabis Prerolls
Description

Hash preroll made from award-winning Apple Fritter (Karma Cup Best Hybrid winner) kief and rosin blend. Features apple, vanilla, and herbal notes. THC 43-50% (24-30% Quebec).

12Dank Sti'x
CategoryCannabis Prerolls
Description

Hash preroll using East Coast Dank'z strain pressed into hash and rolled. Features gas, spicy, and grape popsicle flavors. THC 35-40%, CBD 1-2%.

13Sage n' Sour Hash
CategoryCannabis Hash
Description

Hash product made from Sage n' Sour kief and rosin. Sticky, malleable texture with dark brown color. Features citrus, earthy, and gas flavors. Sativa-dominant. THC 35-45%.

14Wes' Coast Kush Hash
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-16
Description

Canopy Growth Corporation acquired MTL Cannabis for approximately CA$125 million, completed on March 16, 2026. The deal made MTL Cannabis Canada's leading medical cannabis business by revenue and brought MTL's patient network, clinics, and online medical channel under Canopy Growth's umbrella. Key MTL executives joined Canopy's leadership team, and integration of MTL's cultivation and post-harvest operations began immediately. The acquisition was expected to deliver approximately $10 million in run-rate synergies within 18 months, supporting Canopy's target of positive adjusted EBITDA in fiscal 2027.

260+ Licensed Cannabis Brands (via Abba Medix)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MTL's medical subsidiary Abba Medix Corp. sources over 450 SKUs from over 60 brands and more than 35 licensed producers, curating a medical cannabis menu for veterans and other medical patients. This creates a marketplace model where MTL aggregates third-party products for patient access.

mtlcannabis.ca
Strategic tierMinorTypeOthers
Description

Nordico Enterprises Ltd. is one of MTL's three major vendors, supplying packaging materials and construction materials. Nordico, along with Postech Media Inc., comprises over 90% of the company's purchases. Nordico has provided acknowledgement and compliance with MTL's Supplier Code of Conduct.

4Postech Media Inc.
Strategic tierMinorTypeOthers
Description

Postech Media Inc. provides contract packaging, filling, bottling, and labeling services to MTL Cannabis. Along with Nordico, Postech represents over 90% of MTL's vendor purchases. Postech has provided acknowledgement and compliance with MTL's Supplier Code of Conduct.

mtlcannabis.ca
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MTL Cannabis partners with CHC Clinics (chclinics.ca) to direct prospective medical cannabis patients to obtain Medical Documents (authorizations). Patients curious about medical cannabis can be referred to CHC Clinics to receive a medical document, then order MTL flower products through the Abba Medix platform.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

LowKey by MTL Cannabis is a sub-brand offering dessert-flavored cannabis products including Haze, Sativa, and Dessert varieties. The Apple Fritter variety from LowKey won the Best Hybrid award at the 2023 Karma Cup. LowKey products are sold alongside MTL products in Canadian provincial retailers.

7R'Belle (Quebec Sub-brand)
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

R'Belle by MTL Cannabis is a sub-brand sold exclusively in Quebec through the SQDC. Products include Marseille, Versailles, Bastille, Eiffel hash, and Louvre hash — premium hash and flower products tailored for the Quebec market.

mtlcannabis.ca
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MTL Cannabis

Cannabis Cultivation and Distributionmtlcannabis.ca

MTL Cannabis is a Canadian licensed cultivator and processor of premium indoor-grown recreational and medical cannabis, serving provincial retailers, medical patients, and veterans. Acquired by Canopy Growth in March 2026 for CA$125 million, it now operates as a wholly-owned subsidiary.

What MTL Cannabis does

MTL Cannabis is a Canadian licensed cultivator and processor of premium indoor-grown cannabis, founded in 2020 by Montreal brothers Rich and Mitch Perron. The company operates a flower-first portfolio spanning dried flower strains (Sage n' Sour, Cookies n' Cream, Strawberry n' Mintz, Jungl' Cake, Wes' Coast Kush, East Coast Dank'z, Dante'z Inferno, Gas n' Up, 91 OX), hash products (Sage n' Sour Hash, Wes' Coast Kush Hash), and prerolls (Lemon' Ball'r, Apple Sau'z, Dank Sti'x). Core technology centers on an indoor hydroponic cultivation system with a defined 5-step artisan process — indoor cultivation, hang-drying, cold curing, hand thumb trimming, and hand packing — producing flower with THC content ranging from 18-36% depending on strain. Sub-brands LowKey (award-winning dessert strains), R'Belle (Quebec-exclusive sold through SQDC), and MTL Craft (micro-cultivation aggregator) segment the market by price point, geography, and production scale.

MTL Cannabis generates revenue through two primary streams: recreational cannabis sold through provincial distributors and licensed retailers across all Canadian provinces, and medical cannabis distributed through its subsidiaries ABBA Medix Corp. (an online medical marketplace sourcing 450+ SKUs from 60+ brands) and Canada House Clinics Inc. (medical document issuance and patient education). The company sells directly to budtenders and retailers through a dedicated sales channel ([email protected]) and operates the 5 à Sesh product knowledge training program for retail staff. Additional subsidiaries include Montréal Cannabis Médical Inc. (licensed cultivator/processor) and IsoCanMed Inc. (medical cannabis cultivation).

Following the August 2023 listing on the CSE under symbol MTLC and achieving $83.1M in FY2024 revenue, MTL Cannabis was acquired by Canopy Growth Corporation in March 2026 for approximately CA$125 million. The acquisition integrated MTL's patient network, clinics, online medical channel, and premium flower supply into Canopy's operations, positioning the combined entity as Canada's leading medical cannabis business by revenue. The deal targets approximately $10M in run-rate cost synergies within 18 months and supports Canopy Growth's fiscal 2027 positive adjusted EBITDA target. MTL Cannabis now operates as a wholly-owned subsidiary of Canopy Growth (NASDAQ: CGC).

MTL Cannabis firmographics

Firmographics
Name
MTL Cannabis
Legal name
MTL Cannabis Corp.
Website
https://mtlcannabis.ca
Company type
Private
Founded year
2020
Operating status
Acquired
Short description
MTL Cannabis is a Canadian licensed cultivator and processor of premium indoor-grown recreational and medical cannabis, serving provincial retailers, medical patients, and veterans. Acquired by Canopy Growth in March 2026 for CA$125 million, it now operates as a wholly-owned subsidiary.
Ownership category
akta.pro rank

MTL Cannabis industry classification

Industry
Product category
Cannabis Cultivation and Distribution
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro primary industry
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
akta.pro secondary industries
Medical Cannabis Dispensaries (CRANAFAB), Adult-Use (Recreational) Cannabis Dispensaries (CRANAFAA)

Keywords

  • Indoor cannabis cultivation
  • Medical cannabis marketplace
  • Cannabis flower products
  • Cannabis prerolls and hash
  • Licensed cannabis producer

Where MTL Cannabis is headquartered

Location

Headquarters

HQ city
Montreal
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

MTL Cannabis business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Recreational Cannabis Sales: MTL Cannabis sells recreational cannabis products (dried flower, prerolls, hash) through provincial board distributors across Canada. Revenue is generated through product sales at retail. The company claims Canada's leading medical cannabis business by revenue following its Canopy Growth acquisition.
  2. Medical Cannabis Sales: Through subsidiaries Abba Medix Corp. (a medical marketplace sourcing 450+ SKUs from 60+ brands and licensed producers) and Canada House Clinics Inc. (providing medical documents and education services), MTL serves medical cannabis patients including veterans. Revenue is generated through medical cannabis sales to patients.
  3. Wholesale / B2B Flower Supply: MTL Cannabis supplies its premium flower products to retailers and budtenders across Canada, including through its own brand portfolio and sub-brands (LowKey, R'Belle for Quebec, MTL Craft for micro-cultivator showcase).

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

MTL Cannabis product offering

Product offering

Core offering

MTL Cannabis is a flower-first Canadian licensed cultivator and processor that produces and distributes premium indoor-grown cannabis dried flower, prerolls, and hash products. The company operates a five-step artisan production process (indoor cultivation, hang-drying, cold curing, hand trimming, hand packing) across three growing facilities in Canada. Through subsidiaries Abba Medix and Canada House Clinics, it also operates a medical cannabis marketplace and clinic services for veterans and other medical patients.

Product overview

MTL Cannabis is a flower-first Canadian cannabis company offering premium indoor-grown, hang-dried, cold-cured, and hand-trimmed cannabis products. The portfolio spans core dried flower strains (Sage n' Sour, Cookies n' Cream, Strawberry n' Mintz, Jungl' Cake, Wes' Coast Kush, East Coast Dank'z, Dante'z Inferno, Gas n' Up, 91 OX), hash products (Sage n' Sour Hash, Wes' Coast Kush Hash), and prerolls (Lemon' Ball'r, Apple Sau'z, Dank Sti'x). The company operates three sub-brands: MTL Craft (small-batch artisan micro-cultivation via Abba Medix), LowKey (award-winning strains including Karma Cup Best Hybrid winner Apple Fritter), and R'Belle (Quebec-exclusive). The 5 à Sesh program provides budtender education on the hydroponic system and 5-step artisan production process.

Differentiator

Problem solved

Functional benefit

Brands

  • LowKey: Premium cannabis brand featuring strains like Haze, Sativa, and Dessert varieties. LowKey won the 2023 Karma Cup award for Best Hybrid with Apple Fritter.
  • R'Belle
  • MTL Craft

Products and services

  • Sage n' Sour Signature hybrid strain (Sour Diesel x S.A.G.E.) with diesel, peppery, lemon, and cedar notes. THC content 24-30%. Available in 1 oz format for adult-use recreational consumers across Canadian provinces.
  • Cookies n' Cream Hybrid strain (Starfighter x Girl Scout Cookies phenotype) with sweet pastry, hazelnut, tart, and floral flavors. THC 18-25%, CBG 1-2%. Balanced 50% Sativa / 50% Indica.
  • Strawberry n' Mintz Sativa-dominant hybrid (Strawberry Guava x Kush Mints) featuring fresh berry, minty, and earthy flavors. THC 30-36%. Available in 15g and prerolls.
  • Jungl' Cake Indica-dominant hybrid (White Fire x Wedding Cake) with sweet pastry, marshmallow, and nutty notes. THC 28-34%. Available in 1/2 oz format.
  • Wes' Coast Kush Indica-dominant hybrid (OG Kush x hybrid blend) with sweet, earthy, spicy, and diesel flavors. THC 28-36%. Available in 1/2 oz and prerolls.
  • East Coast Dank'z Indica (Grape Gas x Gelato) with diesel, sweet, peppery, and spicy notes. THC 26-31%, CBD under 1%. Available in 7g and prerolls (3x0.5g).
  • Dante'z Inferno Hybrid (Oreoz x Devil Driver) with cookie dough, campfire smores, earthy, spicy, and citrus notes. THC 28-33%. Available in 14g format.
  • Gas n' Up Indica (Venom OG x Humboldt OG) with spicy diesel, black pepper, and earthy wood flavors. THC 27-33%. Available in prerolls.
  • 91 OX Indica-dominant (Biscotti x Scotty2Hotty) with diesel, spicy biscuit, and floral notes. THC 27-33%. Available in 3.5g and prerolls.
  • Lemon' Ball'r Preroll combining Sage n' Sour hash with Sage n' Sour flower, featuring lemon, diesel, and citrus flavors. Dominant terpene: Terpinolene. THC 21-27% in Quebec.
  • Apple Sau'z Hash preroll made from award-winning Apple Fritter (Karma Cup Best Hybrid winner) kief and rosin blend. Features apple, vanilla, and herbal notes. THC 43-50% (24-30% Quebec).
  • Dank Sti'x Hash preroll using East Coast Dank'z strain pressed into hash and rolled. Features gas, spicy, and grape popsicle flavors. THC 35-40%, CBD 1-2%.
  • Sage n' Sour Hash Hash product made from Sage n' Sour kief and rosin. Sticky, malleable texture with dark brown color. Features citrus, earthy, and gas flavors. Sativa-dominant. THC 35-45%.
  • Wes' Coast Kush Hash

Quantifiable outcome

  • MTL Cannabis was positioned as Canada's leading medical cannabis business by revenue following its acquisition by Canopy Growth in March 2026.
  • +3 more outcomes

Companies that use MTL Cannabis

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles4 records

MTL Cannabis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MTL Cannabis partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Canopy Growth CorporationcoreStrategic or Co-development Partner · 16 March 2026Canopy Growth Corporation acquired MTL Cannabis for approximately CA$125 million, completed on March 16, 2026. The deal made MTL Cannabis Canada's leading medical cannabis business by revenue and brought MTL's patient network, clinics, and online medical channel under Canopy Growth's umbrella. Key MTL executives joined Canopy's leadership team, and integration of MTL's cultivation and post-harvest operations began immediately. The acquisition was expected to deliver approximately $10 million in run-rate synergies within 18 months, supporting Canopy's target of positive adjusted EBITDA in fiscal 2027.
  • 60+ Licensed Cannabis Brands (via Abba Medix)minorChannel Partner/ Reseller/ DistributorMTL's medical subsidiary Abba Medix Corp. sources over 450 SKUs from over 60 brands and more than 35 licensed producers, curating a medical cannabis menu for veterans and other medical patients. This creates a marketplace model where MTL aggregates third-party products for patient access.
  • Nordico Enterprises Ltd.minorOthersNordico Enterprises Ltd. is one of MTL's three major vendors, supplying packaging materials and construction materials. Nordico, along with Postech Media Inc., comprises over 90% of the company's purchases. Nordico has provided acknowledgement and compliance with MTL's Supplier Code of Conduct.
  • Postech Media Inc.minorOthersPostech Media Inc. provides contract packaging, filling, bottling, and labeling services to MTL Cannabis. Along with Nordico, Postech represents over 90% of MTL's vendor purchases. Postech has provided acknowledgement and compliance with MTL's Supplier Code of Conduct.
  • CHC Clinics (chclinics.ca)minorChannel Partner/ Reseller/ DistributorMTL Cannabis partners with CHC Clinics (chclinics.ca) to direct prospective medical cannabis patients to obtain Medical Documents (authorizations). Patients curious about medical cannabis can be referred to CHC Clinics to receive a medical document, then order MTL flower products through the Abba Medix platform.
  • LowKey (Sub-brand Partner)minorOEM/ Whitelabel/ Licensing PartnerLowKey by MTL Cannabis is a sub-brand offering dessert-flavored cannabis products including Haze, Sativa, and Dessert varieties. The Apple Fritter variety from LowKey won the Best Hybrid award at the 2023 Karma Cup. LowKey products are sold alongside MTL products in Canadian provincial retailers.
  • R'Belle (Quebec Sub-brand)minorOEM/ Whitelabel/ Licensing PartnerR'Belle by MTL Cannabis is a sub-brand sold exclusively in Quebec through the SQDC. Products include Marseille, Versailles, Bastille, Eiffel hash, and Louvre hash — premium hash and flower products tailored for the Quebec market.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

MTL Cannabis competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MTL Cannabis social profiles

Digital presence

MTL Cannabis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MTL Cannabis leadership team

Management profile

Number of profiles

Profiles8 records

MTL Cannabis subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

MTL Cannabis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MTL Cannabis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MTL Cannabis

What does MTL Cannabis do?

MTL Cannabis is a flower-first Canadian licensed cultivator and processor that produces and distributes premium indoor-grown cannabis dried flower, prerolls, and hash products. The company operates a five-step artisan production process (indoor cultivation, hang-drying, cold curing, hand trimming, hand packing) across three growing facilities in Canada. Through subsidiaries Abba Medix and Canada House Clinics, it also operates a medical cannabis marketplace and clinic services for veterans and other medical patients.

Is MTL Cannabis a public or private company?

MTL Cannabis is a private company. It is classified as corporate owned and is currently acquired.

When was MTL Cannabis founded?

MTL Cannabis was founded in 2020.

Where is MTL Cannabis based?

MTL Cannabis is headquartered in Montreal, Canada, in the North America region.

How does MTL Cannabis make money?

Three revenue lines are on record. Recreational Cannabis Sales are the primary driver. The others are medical Cannabis Sales and wholesale / B2B Flower Supply.

Does MTL Cannabis have an API?

No public API is recorded for MTL Cannabis.

What industry is MTL Cannabis in?

MTL Cannabis's product category is Cannabis Cultivation and Distribution. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketBeatCanopy Growth Targets European Cannabis Expansion After MTL Deal and Cost CutsCanopy Growth has acquired MTL Cannabis and implemented cost-cutting measures as part of its strategy to expand in the European and Canadian cannabis markets. The company aims to improve cultivation quality and output while targeting significant growth in Europe, particularly in Germany, Poland, and the United Kingdom, with long-term revenue targets set between C$100 million and C$150 million annually. Canopy Growth is positioning itself as a premium cannabis provider amid a competitive landscape.YahooCanopy Growth Targets European Cannabis Expansion After MTL Deal and Cost CutsCanopy Growth Corporation has cut costs by more than C$30 million, refinanced operations, and completed the acquisition of MTL Cannabis to strengthen its cultivation and product quality capabilities. The company reported growth across its segments, including 20% in Canadian adult-use cannabis, 18% in medical cannabis, and 10% in Europe, while gross margin improved to 31% (up 600 basis points year over year). CEO Luc Mongeau is positioning the company to expand European revenue from roughly C$40 million annually to more than C$100 million by targeting Germany, Poland, and the U.K. with premium products and an EU GMP-compliant supply chain.AInvestCanopy's $100.36M Revenue Beat Hides a GAAP Trap-Aug. 7 Is the Real TestCanopy Growth reported fiscal 2026 results with $100.36M revenue beating estimates, ending the year with $131.3M net cash after a January 2026 recapitalization, though the company remains unprofitable with a quarterly loss of $0.17/share versus a $0.06 consensus loss. Full-year growth was driven by 20% in Canada adult-use and 18% in Canada medical, with Q4 Canada medical up 27%, while the MTL Cannabis acquisition strengthened its medical segment position. The market's focus has shifted to the August 7, 2026 earnings call, where investors will assess whether management can demonstrate the recent sales improvements are translating into a credible path to profitability.MorningstarCanopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All BusinessesCanopy Growth reported Q1 FY2027 net revenue of $81.2M, up 13% year-over-year, with all business segments contributing. Adjusted gross margin improved to 31% from 25%, and adjusted EBITDA loss narrowed by 59% to $3.2M. The company expects further improvements in the second half of fiscal 2027.TradersunionMTL Cannabis integration yields $8 million cost savings boost Canopy Growth stock toward $1.05 resistanceCanopy Growth reported a 13% increase in Q1 revenue and a 59% year-over-year improvement in adjusted EBITDA loss to $3.2 million, driven by efficiency gains and the integration of MTL Cannabis which has yielded $8 million in cost savings. The company's stock rose 6.08% to $1.01 as these financial improvements bolstered investor sentiment. Technical analysis indicates strong short-term momentum with potential for further upside if the stock breaks above the $1.05 resistance level.BenzingaCanopy Gwth Q4 2026 Earnings Call TranscriptCanopy Growth reported Q4 fiscal 2026 net revenue of $71.2 million, a 10% increase year-over-year, driven by growth in Canadian medical cannabis and international cannabis segments. The company completed the strategic acquisition of MTL Cannabis, positioning it as the leader in the Canadian medical cannabis market, and has already achieved $6 million of its targeted $10 million in annualized cost synergies within two months of closing. Management expressed confidence in achieving positive adjusted EBITDA during fiscal 2027, supported by continued revenue growth, a strengthened balance sheet with $131 million net cash, and expanded operations across Canadian and European markets.The Globe and MailCanopy Growth Closes MTL Cannabis Deal to Cement Lead in Medical MarketCanopy Growth has completed its acquisition of MTL Cannabis, creating what it claims is Canada's leading medical cannabis business by revenue and significantly expanding its premium flower supply. The deal, which brings MTL's patient network, clinics, and online medical channel under Canopy Growth, is expected to deliver approximately $10 million in run-rate synergies within 18 months while supporting the company's target of positive adjusted EBITDA in fiscal 2027. Key MTL executives have joined Canopy's leadership team, and integration of MTL's cultivation and post-harvest operations has already begun.Business Wire BlogCanopy Growth Reports Third Quarter Fiscal 2026 Financial ResultsCanopy Growth reported Q3 FY2026 financial results with flat consolidated net revenue of $75M year-over-year, though the company achieved a 49% narrowing of net loss to $62.6M and a 17% improvement in Adjusted EBITDA loss to $3M. The company maintains strong financial position with $371M in cash and a net cash position of $146M as of December 31, 2025, while its acquisition of MTL Cannabis remains on track to close this quarter and management targets positive Adjusted EBITDA by fiscal 2027. Cannabis segment revenue grew 4% to $52M driven by 15% growth in Canadian medical cannabis and 8% growth in adult-use, though international markets declined 31% due to European supply chain challenges.BNNInvestor Outlook: Canada’s cannabis industry enters new consolidation phaseCanopy Growth has agreed to acquire Montreal-based MTL Cannabis for approximately $179 million, with the transaction expected to close in March, positioning Canopy as a leading player in Canada’s medical cannabis market. MTL generates roughly $84 million in trailing 12-month revenue with a 51% gross margin and is already EBITDA-positive and cash flow-positive, attributes that Canopy CEO Luc Mongeau said will accelerate his company’s path to profitability. The acquisition adds superior cultivation capabilities to Canopy’s platform and supports international expansion, particularly into Europe where demand, especially in Germany, continues to grow.Winnipeg Free PressCanopy Growth signs deal to buy MTL Cannabis in agreement valued at $125MCanopy Growth Corp. has signed a deal to acquire Quebec-based MTL Cannabis Corp. in a transaction valued at approximately $125 million. Under the terms, MTL shareholders will receive 0.32 of a Canopy Growth common share plus 14.4 cents in cash for each MTL share held. The acquisition requires regulatory and MTL shareholder approval, with closing expected before the end of February, and is intended to strengthen Canopy Growth's position in Canada's medical cannabis market.